MENU
+Compare
DXCM
Stock ticker: NASDAQ
AS OF
Dec 24, 10:49 AM (EDT)
Price
$79.04
Change
-$0.50 (-0.63%)
Capitalization
53.47B

DXCM DexCom Forecast, Technical & Fundamental Analysis

a maker of medical devices and glucose monitoring systems

DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DXCM with price predictions
Dec 23, 2024

Momentum Indicator for DXCM turns positive, indicating new upward trend

DXCM saw its Momentum Indicator move above the 0 level on December 20, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where DXCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DXCM advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

DXCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 287 cases where DXCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DXCM moved out of overbought territory on December 05, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for DXCM turned negative on December 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DXCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.707) is normal, around the industry mean (23.300). P/E Ratio (106.108) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (2.565) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (16.207) is also within normal values, averaging (43.338).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DXCM is expected to report earnings to rise 15.78% to 52 cents per share on February 06

DexCom DXCM Stock Earnings Reports
Q4'24
Est.
$0.52
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.07
The last earnings report on October 24 showed earnings per share of 44 cents, beating the estimate of 43 cents. With 86.47K shares outstanding, the current market capitalization sits at 53.47B.
A.I. Advisor
published General Information

General Information

a maker of medical devices and glucose monitoring systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6340 Sequence Drive
Phone
+1 858 200-0200
Employees
9600
Web
https://www.dexcom.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLK16.120.44
+2.81%
PT Telekomunikasi Indonesia
VNET3.620.06
+1.69%
VNET Group
PK14.900.05
+0.34%
Park Hotels & Resorts
EQ0.60-0.01
-1.64%
Equillium
PGEN0.75-0.02
-2.16%
Precigen

DXCM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
-0.62%
CERS - DXCM
42%
Loosely correlated
N/A
IRMD - DXCM
34%
Loosely correlated
-1.06%
AORT - DXCM
33%
Loosely correlated
-0.70%
ACRS - DXCM
33%
Loosely correlated
+6.25%
COO - DXCM
32%
Poorly correlated
-0.98%
More